WHAT WE DO
Biohope Ltd. is a biomedical company focused in the research and development of novel solutions, to personalize and optimize the clinical management of chronic inflammation in patients under treatment with immunosuppressive and/or immunomodulatory therapies.
To develop innovative, honest, simple, and viable science to help improve human lives.
Biohope strives to be a leader in the generation of scientifically and socioeconomically sustainable innovative solutions in the field of immunologically based diseases.
Creative innovation – Quality work – Commitment to the project and to society Scientific, economic, and social transparency – Free expression of talent
CORE GOALS
To facilitate medical doctors to personalize and optimize the medical treatment in their patients with organ transplantation and rheumatoid arthritis.
To market INMUNOBIOGRAM as a simple & highly scalable technology easy to use.
Start worldwide sales from 2020
Create a highly motivating and creative company environment.
WE ARE ON PLAN
Biohope is a fast-growing company that has achieved significant goals in less than three years of existence, and we keep on moving!
INMUNOBIOGRAM R+D Plan
RENAL TRANSPLANTATION. Biohope has successfully finished a National Study (BH-Pilot). We work with 8 top-class Transplant Units of 4 EU countries and MGH (Harvard School of Medicine) in an International Multicenter clinical Study
RHEUMATOID ARTHRITIS. Biohope is initiating a national study to adapt the Inmunobiogram® technology to this new indication.